Liyan Bai
Impact in
-
- Liver physiology and pathology
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 10
- Drug Transport and Resistance Mechanisms 3
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 2
-
- Histone Deacetylase Inhibitors Research 2
- Cancer therapeutics and mechanisms 2
- Co-authors
- Myung Ho Jeong (7 shared papers)Hae Jin Kee (5 shared papers)Seung‐Jung Kee (4 shared papers)Masayoshi Namba (4 shared papers)Koichiro Mihara (2 shared papers)Hao Wu (1 shared paper)Wenyan Zhang (1 shared paper)Xinguo Wang (1 shared paper)
- Journals
- Journal of Cancer Research and Clinical Oncology (2 papers)Experimental Cell Research (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Nature Communications (1 paper)Journal of Cardiovascular Pharmacology and Therapeutics (1 paper)
- Partner nations
- ChinaSouth KoreaJapan
In The Last Decade
Liyan Bai
29 papers receiving 371 citations
Peers
Comparison fields: 5 of 75
- Hepatology 42
- Cancer Research 65
- Genetics 28
- Oncology 60
- Molecular Biology 163
Countries citing papers authored by Liyan Bai
This map shows the geographic impact of Liyan Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Bai more than expected).
Fields of papers citing papers by Liyan Bai
This network shows the impact of papers produced by Liyan Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Bai. The network helps show where Liyan Bai may publish in the future.
Co-authors
The 25 scholars most cited alongside Liyan Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 61 | |
| 2 | 2021 | 49 | |
| 3 | 1993 | 42 | |
| 4 | 2000 | 27 | |
| 5 | 2021 | 23 | |
| 6 | 1993 | 21 | |
| 7 | 2020 | 19 | |
| 8 | 2022 | 18 | |
| 9 | 1989 | 15 | |
| 10 | 1992 | 14 | |
| 11 | 2021 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 1998 | 11 | |
| 14 | 1991 | 8 | |
| 15 | 1990 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2025 | 5 | |
| 18 | 1991 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 3 |
About Liyan Bai
Liyan Bai is a scholar working on Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Cancer Research, having authored 31 papers that have together received 376 indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Cardiac Fibrosis and Remodeling (3 papers), HER2/EGFR in Cancer Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer therapeutics and mechanisms (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hepatology (42 citations), Cancer Research (65 citations), Genetics (28 citations), Oncology (60 citations) and Molecular Biology (163 citations). Liyan Bai has collaborated with scholars based in China, South Korea and Japan. Frequent co-authors include Myung Ho Jeong, Hae Jin Kee, Seung‐Jung Kee, Masayoshi Namba, Koichiro Mihara, Hao Wu, Wenyan Zhang, Xinguo Wang, Masahiro Miyazaki and Yoichi Kondo. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Experimental Cell Research, Journal of Cellular and Molecular Medicine, Nature Communications and Journal of Cardiovascular Pharmacology and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.